263 related articles for article (PubMed ID: 30061358)
1. ARID5B regulates metabolic programming in human adaptive NK cells.
Cichocki F; Wu CY; Zhang B; Felices M; Tesi B; Tuininga K; Dougherty P; Taras E; Hinderlie P; Blazar BR; Bryceson YT; Miller JS
J Exp Med; 2018 Sep; 215(9):2379-2395. PubMed ID: 30061358
[TBL] [Abstract][Full Text] [Related]
2. NK cells generate memory-type responses to human cytomegalovirus-infected fibroblasts.
Newhook N; Fudge N; Grant M
Eur J Immunol; 2017 Jun; 47(6):1032-1039. PubMed ID: 28475279
[TBL] [Abstract][Full Text] [Related]
3. Late Development of FcεRγ
Muccio L; Falco M; Bertaina A; Locatelli F; Frassoni F; Sivori S; Moretta L; Moretta A; Della Chiesa M
Front Immunol; 2018; 9():1050. PubMed ID: 29868012
[TBL] [Abstract][Full Text] [Related]
4. Adaptive Reconfiguration of Natural Killer Cells in HIV-1 Infection.
Peppa D; Pedroza-Pacheco I; Pellegrino P; Williams I; Maini MK; Borrow P
Front Immunol; 2018; 9():474. PubMed ID: 29616021
[TBL] [Abstract][Full Text] [Related]
5. CD2-CD58 interactions are pivotal for the activation and function of adaptive natural killer cells in human cytomegalovirus infection.
Rölle A; Halenius A; Ewen EM; Cerwenka A; Hengel H; Momburg F
Eur J Immunol; 2016 Oct; 46(10):2420-2425. PubMed ID: 27469079
[TBL] [Abstract][Full Text] [Related]
6. Human Cytomegalovirus Antigen Presentation by HLA-DR+ NKG2C+ Adaptive NK Cells Specifically Activates Polyfunctional Effector Memory CD4+ T Lymphocytes.
Costa-García M; Ataya M; Moraru M; Vilches C; López-Botet M; Muntasell A
Front Immunol; 2019; 10():687. PubMed ID: 31001281
[TBL] [Abstract][Full Text] [Related]
7. Characterization of IFNγ-producing natural killer cells induced by cytomegalovirus reactivation after haploidentical hematopoietic stem cell transplantation.
Jin F; Lin H; Gao S; Wang H; Yan H; Guo J; Hu Z; Jin C; Wang Y; Wang Z; Zhao Y; Liu Y; Zheng X; Tan Y; Li W; Dai Y; Yang Y
Oncotarget; 2017 Jan; 8(1):51-63. PubMed ID: 27980216
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of cytokine-driven NK cell IFN-γ production after vaccination of HCMV infected Africans.
Darboe A; Danso E; Clarke E; Umesi A; Touray E; Wegmuller R; Moore SE; Riley EM; Goodier MR
Eur J Immunol; 2017 Jun; 47(6):1040-1050. PubMed ID: 28383105
[TBL] [Abstract][Full Text] [Related]
9. NKG2C(+)CD57(+) Natural Killer Cell Expansion Parallels Cytomegalovirus-Specific CD8(+) T Cell Evolution towards Senescence.
Heath J; Newhook N; Comeau E; Gallant M; Fudge N; Grant M
J Immunol Res; 2016; 2016():7470124. PubMed ID: 27314055
[TBL] [Abstract][Full Text] [Related]
10. Regulation of Adaptive NK Cells and CD8 T Cells by HLA-C Correlates with Allogeneic Hematopoietic Cell Transplantation and with Cytomegalovirus Reactivation.
Horowitz A; Guethlein LA; Nemat-Gorgani N; Norman PJ; Cooley S; Miller JS; Parham P
J Immunol; 2015 Nov; 195(9):4524-36. PubMed ID: 26416275
[TBL] [Abstract][Full Text] [Related]
11. Latent cytomegalovirus infection enhances anti-tumour cytotoxicity through accumulation of NKG2C+ NK cells in healthy humans.
Bigley AB; Rezvani K; Shah N; Sekine T; Balneger N; Pistillo M; Agha N; Kunz H; O'Connor DP; Bollard CM; Simpson RJ
Clin Exp Immunol; 2016 Aug; 185(2):239-51. PubMed ID: 26940026
[TBL] [Abstract][Full Text] [Related]
12. Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function.
Schlums H; Cichocki F; Tesi B; Theorell J; Beziat V; Holmes TD; Han H; Chiang SC; Foley B; Mattsson K; Larsson S; Schaffer M; Malmberg KJ; Ljunggren HG; Miller JS; Bryceson YT
Immunity; 2015 Mar; 42(3):443-56. PubMed ID: 25786176
[TBL] [Abstract][Full Text] [Related]
13. Adaptive Features of Natural Killer Cells in Multiple Sclerosis.
Moreira A; Alari-Pahissa E; Munteis E; Vera A; Zabalza A; Llop M; Villarrubia N; Costa-García M; Álvarez-Lafuente R; Villar LM; López-Botet M; Martínez-Rodríguez JE
Front Immunol; 2019; 10():2403. PubMed ID: 31681293
[TBL] [Abstract][Full Text] [Related]
14. Co-infection of Cytomegalovirus and Epstein-Barr Virus Diminishes the Frequency of CD56
Lam JKP; Azzi T; Hui KF; Wong AMG; McHugh D; Caduff N; Chan KH; Münz C; Chiang AKS
Front Immunol; 2020; 11():1231. PubMed ID: 32625211
[TBL] [Abstract][Full Text] [Related]
15. Relationship of NKG2C Copy Number with the Distribution of Distinct Cytomegalovirus-Induced Adaptive NK Cell Subsets.
Muntasell A; Pupuleku A; Cisneros E; Vera A; Moraru M; Vilches C; López-Botet M
J Immunol; 2016 May; 196(9):3818-27. PubMed ID: 26994220
[TBL] [Abstract][Full Text] [Related]
16. Systematic characterization of human CD8+ T cells with natural killer cell markers in comparison with natural killer cells and normal CD8+ T cells.
Ohkawa T; Seki S; Dobashi H; Koike Y; Habu Y; Ami K; Hiraide H; Sekine I
Immunology; 2001 Jul; 103(3):281-90. PubMed ID: 11454057
[TBL] [Abstract][Full Text] [Related]
17. Critical Role of CD2 Co-stimulation in Adaptive Natural Killer Cell Responses Revealed in NKG2C-Deficient Humans.
Liu LL; Landskron J; Ask EH; Enqvist M; Sohlberg E; Traherne JA; Hammer Q; Goodridge JP; Larsson S; Jayaraman J; Oei VYS; Schaffer M; Taskén K; Ljunggren HG; Romagnani C; Trowsdale J; Malmberg KJ; Béziat V
Cell Rep; 2016 May; 15(5):1088-1099. PubMed ID: 27117418
[TBL] [Abstract][Full Text] [Related]
18. Natural Killer Cells Adapt to Cytomegalovirus Along a Functionally Static Phenotypic Spectrum in Human Immunodeficiency Virus Infection.
Holder KA; Lajoie J; Grant MD
Front Immunol; 2018; 9():2494. PubMed ID: 30483249
[TBL] [Abstract][Full Text] [Related]
19. Coordinated expansion of both memory T cells and NK cells in response to CMV infection in humans.
Bayard C; Lepetitcorps H; Roux A; Larsen M; Fastenackels S; Salle V; Vieillard V; Marchant A; Stern M; Boddaert J; Bajolle F; Appay V; Sauce D
Eur J Immunol; 2016 May; 46(5):1168-79. PubMed ID: 26910859
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of NK cell receptor repertoire in adults and very elderly subjects with cytomegalovirus infection.
Juárez-Vega G; Rangel-Ramírez V; Monsiváis-Urenda A; Niño-Moreno P; Garcia-Sepúlveda C; Noyola DE; González-Amaro R
Hum Immunol; 2017 Mar; 78(3):274-280. PubMed ID: 28093266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
